Terry Gould
Partner & Head of Direct Investments, Chicago
As Head of Direct Investments, Terry invests in venture and growth-oriented companies in the medical device and biopharma sectors.
Terry sits on the Boards of Directors of INC Research, Light Sciences Oncology, Proteus Biomedical and OncoMed. He is responsible for several other successful investments: CombinatoRx (NASDAQ: CRXX), Heartport (bought by Johnson and Johnson), Jazz Pharmaceuticals (NASDAQ: JAZZ), NxStage Medical, Revivant (bought by Zoll), Spinal Dynamics (bought by Medtronic), Vivant Medical (bought by Tyco International Ltd.) and Xtent (NASDAQ: XTNT).
Previous Experience:
Brinson Partners/UBS Global Asset Management
Trinity Ventures
Boston Consulting Group
Academic:
Dartmouth College, BA
Stanford University, MBA
Executive Assistant: Vicki Loffredo